Overview of Chinese Pharmacopoeia 2025 Edition Volume Ⅲ
10.19778/j.chp.2025.01.005
- VernacularTitle:2025年版《中国药典》三部增修订概况
- Author:
CAO Yan
;
ZHAO Xiong
;
WANG Xiaojuan
;
CHEN Huiyi
;
LI Huiyi
- Publication Type:Journal Article
- Keywords:
Chinese Pharmacopoeia;
drug standard;
new admission and revision
- From:
Drug Standards of China
2025;26(1):028-033
- CountryChina
- Language:Chinese
-
Abstract:
“Chinese Pharmacopoeia” is the legal basis for drug development, production, operation, use and management in China, and the Chinese Pharmacopoeia 2025 Edition is going to be issued and implemented. This article introduces the revision and amendment situations, analyzes the characteristics of the new edition of the Pharmacopoeia and the future development direction of national standards for better understanding and implementation of the latest edition of pharmacopoeia.
- Full text:202503111316376267820250205.pdf
